Synthesized and optimized 5 distinct peptide hydrogels, including KYFIL, under varying experimental
conditions to mimic brain tissue stiffness for targeted treatments, such as stroke.
Cultured oligodendrocyte progenitor cells under sterile conditions to evaluate cell viability
within the synthesized hydrogels.
Conducted rheological testing using an oscillatory rheometer to quantify hydrogel viscoelasticity
and tune mechanical properties to match native brain ECM.
Performed image-based morphological analyses to validate hydrogel structure, porosity, and
consistency across formulations using microscopy techniques.
Contributed to parallel studies on heart valve disease: one on serotonin's role in mitral regurgitation, the other on siRNA therapies targeting cadherin-11 in aortic stenosis.
Performed Western blot, qPCR, and mouse anatomical dissection to investigate molecular mechanisms of valvular diseases, gaining practical insights into potential therapeutic targets.
Presented research findings in a symposium to faculty, professionals, and students.